Einzeltreffer — DigiBib

A system and method for detecting and treating symptoms of early decompensation utilizing a cardiac rhythm management. The system applies an electrical stimulus to the patient's heart at a first set of pacing parameters including a lower rate limit (LRL) setting, and acquires a coronary venous pressure (CVP) signal from a pressure sensor implanted in a coronary vein of the patient. An average coronary venous end diastolic pressure (CV-EDP) value is calculated from the CVP signal. The system monitors the average CV-EDP value over a predetermined interval, and dynamically adjusts the LRL setting responsive to the detection of a first or a second predetermined event based on the average CV-EDP value.

Titel:	System and method for decompensation detection and treatment based on patient hemodynamics
Autor/in / Beteiligte Person:	Cardiac Pacemakers, Inc.
Link:	View record in USPTO Patent Grants (Volltext)
Veröffentlichung:	2014
Medientyp:	Patent
Sonstiges:	Nachgewiesen in: USPTO Patent Grants Sprachen: English Patent Number: 8,825,156 Publication Date: September 02, 2014 Appl. No: 13/861947 Application Filed: April 12, 2013 Assignees: Cardiac Pacemakers, Inc. (St. Paul, MN, US) Claim: 1. A method of operating an implanted cardiac rhythm management system in a patient, the method comprising: applying an electrical stimulus to the patient's heart at a first set of pacing parameters including a lower rate limit (LRL) setting; acquiring a coronary venous pressure (CVP) signal from a pressure sensor implanted in a coronary vein of the patient; calculating an average coronary venous end diastolic pressure (CV-EDP) value from the CVP signal; monitoring the average CV-EDP value, such monitoring including detecting an increase in the average CV-EDP value above a threshold indicative of decompensation and subsequently detecting a reduction in the average CV-EDP value below the threshold indicative of termination of the decompensation; and dynamically adjusting the LRL setting based on the average CV-EDP value by increasing the LRL setting in response to detecting the increase in the average CV-EDP value above the threshold and reducing the LRL setting in response to detecting the reduction in the average CV-EDP value below the threshold. Claim: 2. The method of claim 1 further comprising initiating a prescribed time limit based on the LRL setting being increased in response to detecting the increase in the average CV-EDP value above the threshold, wherein dynamically adjusting the LRL setting includes lowering the LRL setting based on expiration of the prescribed time limit if the reduction in the average CV-EDP value below the threshold is not detected during the prescribed time limit. Claim: 3. The method of claim 1 wherein dynamically adjusting the LRL setting comprises further increasing the LRL setting if the reduction in the average CV-EDP value below the threshold has not been detected following the LRL setting being increased in response to detecting the increase in the average CV-EDP value above the threshold. Claim: 4. The method of claim 1 wherein dynamically adjusting the LRL setting comprises further increasing the LRL setting a predetermined number of times if the reduction in the average CV-EDP value below the threshold has not been detected following one or more previous increases of the LRL setting. Claim: 5. The method of claim 1 further comprising reducing the LRL setting in response to an expiration of a predetermined time period for applying the electrical stimulus at the increased LRL setting. Claim: 6. The method of claim 1 wherein calculating the average CV-EDP value includes generating a CVP waveform based on the CVP signal and calculating an average CV-EDP value over a predetermined interval based on the CVP waveform. Claim: 7. An implantable rate adaptive cardiac rhythm management system configured for applying pacing stimuli to a patient's heart, the pacing stimuli defined by pacing parameters including a pacing rate and an LRL setting, the system comprising: a plurality of implantable medical electrical leads configured to sense cardiac electrical activity and to deliver the pacing stimuli, at least one of the leads being configured for chronic implantation within a coronary vein of the patient's heart and including a pressure sensor configured to generate a coronary venous pressure (CVP) signal indicative of fluid pressure within the coronary vein; an implantable pulse generator operatively coupled to the leads configured to generate the pacing stimuli, the pulse generator including a control system configured to: acquire the CVP signal from the pressure sensor; calculate an average coronary venous end diastolic pressure (CV-EDP) value from the CVP signal; monitor the calculated average CV-EDP value, such monitoring including detecting an increase in the average CV-EDP value indicative of decompensation symptoms and detecting a reduction in the average CV-EDP value indicative of termination of the decompensation symptoms; and dynamically adjust the LRL setting based on the calculated average CV-EDP value by increasing the LRL setting in response to detecting the increase in the average CV-EDP value, maintaining the LRL setting at the increased setting for a prescribed time interval, and further increasing the LRL setting if the reduction in the average CV-EDP value is not detected during the prescribed time interval. Claim: 8. The system of claim 7 wherein the pulse generator is further configured to estimate and monitor average left ventricular end diastolic pressure (LV-EDP) values based on the CVP signal. Claim: 9. The system of claim 7 wherein the pulse generator is further configured to dynamically adjust the LRL setting by increasing the LRL setting a predetermined number of times but preventing the LRL setting from exceeding a maximum pacing rate limit. Claim: 10. The system of claim 7 wherein the pulse generator is further configured to dynamically adjust the LRL setting by reducing the LRL setting in response to detecting the reduction in the average CV-EDP value indicating the termination of early decompensation symptoms. Claim: 11. The system of claim 7 wherein the pulse generator is configured to: detect the increase in the average CV-EDP value indicative of decompensation symptoms by detecting the average CV-EDP value increasing above a threshold indicative of decompensation, detect the reduction in the average CV-EDP value by detecting a reduction in the average CV-EDP value below the threshold. Claim: 12. An implantable rate adaptive cardiac rhythm management system configured for applying pacing stimuli to a patient's heart, the pacing stimuli defined by pacing parameters including a LRL setting, the system comprising: a pressure sensor configured for chronic implantation within a coronary vein of the patient's heart to generate a coronary venous pressure (CVP) signal indicative of fluid pressure within the coronary vein; and an implantable pulse generator operatively coupled to the pressure sensor and configured to generate a pacing stimuli, the pulse generator including a control system configured to: acquire the CVP signal from the pressure sensor; calculate an average coronary venous end diastolic pressure (CV-EDP) value from the CVP signal; monitor the calculated average CV-EDP value, such monitoring including detecting an increase in the average CV-EDP value above a threshold indicative of decompensation symptoms and detecting a reduction in the average CV-EDP value below the threshold; and dynamically adjust the LRL setting based on the calculated average CV-EDP value by increasing the LRL setting in response to detecting the increase in the average CV-EDP value above the threshold and reducing the LRL setting in response to detecting the reduction in the average CV-EDP value below the threshold. Claim: 13. The system of claim 12 wherein the control system is configured to initiate a prescribed time limit based on the LRL setting being increased, and lower the LRL setting based on expiration of the prescribed time limit if the reduction in the average CV-EDP value below the threshold is not detected during the prescribed time limit. Claim: 14. The system of claim 12 wherein the control system is configured to increase the LRL setting if the reduction in the average CV-EDP value below the threshold has not been detected following the LRL setting being increased in response to detecting the increase in the average CV-EDP value above the threshold. Claim: 15. The system of claim 12 wherein the control system is configured to increase the LRL setting a predetermined number of times if the reduction in the average CV-EDP value below the threshold has not been detected following one or more previous increases of the LRL setting. Current U.S. Class: 607/9 Patent References Cited: 4686987 August 1987 Salo et al. ; 4708143 November 1987 Schroeppel ; 4967755 November 1990 Pohndorf ; 5129394 July 1992 Mehra ; 5156147 October 1992 Warren et al. ; 5324326 June 1994 Lubin ; 5356883 October 1994 Kuo et al. ; 5464434 November 1995 Alt ; 5480412 January 1996 Mouchawar et al. ; 5626623 May 1997 Kieval et al. ; 6026324 February 2000 Carlson ; 6119040 September 2000 Chirife ; 6277078 August 2001 Porat et al. ; 6278894 August 2001 Salo et al. ; 6366811 April 2002 Carlson ; 6580946 June 2003 Struble ; 6666826 December 2003 Salo et al. ; 6839593 January 2005 Sun et al. ; 6892095 May 2005 Salo ; 6934586 August 2005 Struble et al. ; 6944499 September 2005 Tang et al. ; 6945939 September 2005 Turcott ; 6970742 November 2005 Mann et al. ; 7062323 June 2006 Carlson et al. ; 7195594 March 2007 Eigler et al. ; 7198603 April 2007 Penner et al. ; 7200439 April 2007 Zdeblick et al. ; 7206637 April 2007 Salo ; 7233821 June 2007 Hettrick et al. ; 7269460 September 2007 Chinchoy ; 7272443 September 2007 Min et al. ; 7389142 June 2008 Holmstrom ; 7409244 August 2008 Salo et al. ; 7457663 November 2008 Kalgren et al. ; 8417336 April 2013 Maskara et al. ; 8423140 April 2013 Maskara et al. ; 8583232 November 2013 Maskara et al. ; 2001/0010009 July 2001 Bakels et al. ; 2002/0188329 December 2002 Struble ; 2003/0074029 April 2003 Deno et al. ; 2003/0130581 July 2003 Salo et al. ; 2003/0181938 September 2003 Roth et al. ; 2003/0204209 October 2003 Burnes et al. ; 2004/0138571 July 2004 Salo et al. ; 2004/0230131 November 2004 Kassab et al. ; 2005/0137631 June 2005 Yu et al. ; 2005/0137635 June 2005 Molin ; 2006/0089679 April 2006 Zhu et al. ; 2006/0224190 October 2006 Gill et al. ; 2006/0247692 November 2006 Yang et al. ; 2006/0247702 November 2006 Stegemann et al. ; 2006/0271121 November 2006 Ding et al. ; 2006/0276849 December 2006 Carlson et al. ; 2006/0293714 December 2006 Salo et al. ; 2007/0035202 February 2007 Imai ; 2007/0088221 April 2007 Stahmann ; 2007/0112388 May 2007 Salo ; 2007/0142732 June 2007 Brockway et al. ; 2007/0149890 June 2007 Li et al. ; 2007/0239218 October 2007 Carlson et al. ; 2007/0239219 October 2007 Salo et al. ; 2007/0249945 October 2007 Li et al. ; 2008/0082135 April 2008 Arcot-Krishnamurthy et al. ; 2008/0281367 November 2008 Zhang et al. ; 2009/0149766 June 2009 Shuros ; 2009/0204163 August 2009 Shuros et al. ; 2010/0042175 February 2010 Liu et al. ; 2010/0305635 December 2010 Liu et al. ; 2010/0305649 December 2010 Maskara et al. ; 2010/0305650 December 2010 Maskara et al. ; 2013/0079487 March 2013 Faust et al. ; 2013/0226257 August 2013 Maskara et al. ; 0498533 August 1992 ; 8308939 November 1996 ; 2007512044 May 2007 ; WO0113792 March 2001 ; WO2007075321 May 2007 ; WO2007099533 September 2007 ; WO2007115188 October 2007 ; WO2008088897 July 2008 Other References: Benchimol, Alberto et al., “Hemodynamic consequences of atrial and ventricular pacing in patients with normal and abnormal hearts”, American Journal of Medicine, vol. 39, No. 6, Dec. 1, 1965, 911-922. cited by applicant ; International Search Report and Written Opinion issued in PCT/US2008/080778, dated Feb. 12, 2009. cited by applicant ; International Search Report and Written Opinion issued in PCT/US2010/035949, dated Oct. 26, 2010, 18 pages. cited by applicant ; International Search Report and Written Opinion issued in PCT/US2010/036137, mailed Oct. 28, 2010. cited by applicant ; International Search Report and Written Opinion issued in PCT/US2010/036174, mailed Jul. 21, 2010, 15 pages. cited by applicant Primary Examiner: Dietrich, Joseph Attorney, Agent or Firm: Faegre Baker Daniels LLP

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

System and method for decompensation detection and treatment based on patient hemodynamics